Empresa Melinta Therapeutics, Inc.
Acciones
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 48 | 03/08/20 | |
Susan Blum
DFI | Director of Finance/CFO | 52 | 01/01/16 |
Compliance Officer | 45 | - | |
Jisoo Park
PRN | Corporate Officer/Principal | - | 06/07/21 |
Kristen Allgor
HRO | Human Resources Officer | - | 16/11/20 |
John Harlow
PRN | Corporate Officer/Principal | - | 30/03/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Jonathan Leff
BRD | Director/Board Member | 55 | 20/04/20 |
Director/Board Member | - | 20/04/20 | |
Director/Board Member | - | 20/04/20 | |
Compliance Officer | 45 | - | |
Chief Executive Officer | 48 | 03/08/20 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 13 750 691 | 13 578 334 ( 98,75 %) | 0 | 98,75 % |
Información de la empresa
Melinta Therapeutics, Inc.
389 Interpace Parkway Suite 450
07054, Parsippany
+908-617-1300
http://melinta.com![Dirección Melinta Therapeutics, Inc.](https://cdn.zonebourse.com/static/address/55178946.png)
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+16,13 % | 122 mil M | |
+19,65 % | 113 mil M | |
+18,86 % | 26,49 mil M | |
-23,84 % | 19,4 mil M | |
-18,28 % | 16,24 mil M | |
-45,95 % | 15,15 mil M | |
-19,28 % | 15,4 mil M | |
+63,81 % | 14,93 mil M | |
+1,94 % | 13,52 mil M |